Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$16.3M Buy
241,702
+103,109
+74% +$6.87M 0.07% 273
2026
Q1
$8.7M Buy
+138,593
New +$9.65M 0.05% 345
2022
Q4
Sell
-13,896
Closed -$1.12M 541
2022
Q3
$1.12M Hold
13,896
0.02% 450
2022
Q2
$1.04M Hold
13,896
0.03% 287
2022
Q1
$1.78M Hold
13,896
0.04% 255
2021
Q4
$1.86M Buy
+13,896
New +$2M 0.04% 258
2017
Q3
Sell
-18,080
Closed -$331K 557
2017
Q2
$331K Buy
+18,080
New +$334K 0.01% 526

Other funds holding DXCM

Tredje AP-fonden's DXCM Position: Q2 2026 in Review

Tredje AP-fonden increased its DexCom (DXCM) stake by 74% in Q2 2026, buying an estimated $6.87M and bringing the position to 241,702 shares worth $16.3M. The position accounts for 0.07% of the portfolio, ranked #273.

Tredje AP-fonden first reported a position in DXCM in Q2 2017 and has held it in 7 quarters since. 968 funds tracked by Wall St. Rank hold DXCM as of Q2 2026.

  • Tredje AP-fonden held 241,702 shares of DexCom worth $16.3M as of Q2 2026.
  • Tredje AP-fonden bought 103,109 DexCom shares in Q2 2026, an estimated $6.87M.
  • DexCom made up 0.07% of Tredje AP-fonden's portfolio in Q2 2026, its #273 holding.
  • Tredje AP-fonden first reported a position in DexCom in Q2 2017 and has held it in 7 quarters since.
  • 968 funds tracked by Wall St. Rank held DexCom as of Q2 2026.

Based on Tredje AP-fonden's 13F filing for Q2 2026, filed 10 Aug 2026.